These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
929 related articles for article (PubMed ID: 28077694)
1. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694 [TBL] [Abstract][Full Text] [Related]
2. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection. Costello SP; Tucker EC; La Brooy J; Schoeman MN; Andrews JM Clin Infect Dis; 2016 Apr; 62(7):908-14. PubMed ID: 26628567 [TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585 [TBL] [Abstract][Full Text] [Related]
4. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review. Woodworth MH; Carpentieri C; Sitchenko KL; Kraft CS Gut Microbes; 2017 May; 8(3):225-237. PubMed ID: 28129018 [TBL] [Abstract][Full Text] [Related]
5. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation. Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ mBio; 2016 Dec; 7(6):. PubMed ID: 27999162 [TBL] [Abstract][Full Text] [Related]
6. Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection. Kim KO; Schwartz MA; Lin OST; Chiorean MV; Gluck M Adv Ther; 2019 Aug; 36(8):2052-2061. PubMed ID: 31154629 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis. Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143 [TBL] [Abstract][Full Text] [Related]
8. [Fecal microbiota transplantation, a novel therapy for recurrent Clostridium difficile infection]. Terveer EM; van Beurden YH; Kuijper EJ; Keller JJ Ned Tijdschr Tandheelkd; 2016 Sep; 123(9):406-9. PubMed ID: 27643493 [TBL] [Abstract][Full Text] [Related]
9. [Indication selection and clinical application strategies of fecal microbiota transplantation]. Zhang XY; Chen QY; Li N; Qin HL Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):509-515. PubMed ID: 32842434 [TBL] [Abstract][Full Text] [Related]
10. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes. Anand R; Song Y; Garg S; Girotra M; Sinha A; Sivaraman A; Phillips L; Dutta SK Dig Dis Sci; 2017 Apr; 62(4):1002-1008. PubMed ID: 28181098 [TBL] [Abstract][Full Text] [Related]
11. Faecal microbiota transplantation for recurrent Clostridium difficile infection and beyond: risks and regulation. Goldenberg SD J Hosp Infect; 2016 Feb; 92(2):115-6. PubMed ID: 26792682 [No Abstract] [Full Text] [Related]
12. Fecal microbiota transplantation for the treatment of Clostridium difficile infection. Rao K; Safdar N J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412 [TBL] [Abstract][Full Text] [Related]
13. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis? Tang G; Yin W; Liu W Diagn Microbiol Infect Dis; 2017 Aug; 88(4):322-329. PubMed ID: 28602517 [TBL] [Abstract][Full Text] [Related]
14. A Practical Method for Preparation of Fecal Microbiota Transplantation. Perez E; Lee CH; Petrof EO Methods Mol Biol; 2016; 1476():259-67. PubMed ID: 27507347 [TBL] [Abstract][Full Text] [Related]
15. An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive. Brumbaugh DE; De Zoeten EF; Pyo-Twist A; Fidanza S; Hughes S; Dolan SA; Child J; Dominguez SR J Pediatr; 2018 Mar; 194():123-127.e1. PubMed ID: 29198534 [TBL] [Abstract][Full Text] [Related]
20. Does the donor matter? Donor vs patient effects in the outcome of a next-generation microbiota-based drug trial for recurrent Clostridium difficile infection. Ray A; Jones C Future Microbiol; 2016 May; 11():611-6. PubMed ID: 26986546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]